U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C13H14N2O.C7H6O3
Molecular Weight 352.3838
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHENYRAMIDOL SALICYLATE

SMILES

OC(=O)C1=CC=CC=C1O.OC(CNC2=CC=CC=N2)C3=CC=CC=C3

InChI

InChIKey=HICVRAOITHDABM-UHFFFAOYSA-N
InChI=1S/C13H14N2O.C7H6O3/c16-12(11-6-2-1-3-7-11)10-15-13-8-4-5-9-14-13;8-6-4-2-1-3-5(6)7(9)10/h1-9,12,16H,10H2,(H,14,15);1-4,8H,(H,9,10)

HIDE SMILES / InChI

Molecular Formula C13H14N2O
Molecular Weight 214.2631
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula C7H6O3
Molecular Weight 138.1207
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

PHENYRAMIDOL (ANALEXIN®), also known as fenyramidol, is an aminopyridine derivative, used as analgesic and muscle relaxant. It is considered as a drug that possibly causes hepatotoxicity.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Analexin

Approved Use

Analgesic, Muscle relaxant

Launch Date

1959
Doses

Doses

DosePopulationAdverse events​
400 mg 2 times / day multiple, oral
Dose: 400 mg, 2 times / day
Route: oral
Route: multiple
Dose: 400 mg, 2 times / day
Sources:
unhealthy, 70 years
n = 1
Health Status: unhealthy
Age Group: 70 years
Sex: M
Population Size: 1
Sources:
Disc. AE: Liver injury...
AEs leading to
discontinuation/dose reduction:
Liver injury
Sources:
AEs

AEs

AESignificanceDosePopulation
Liver injury Disc. AE
400 mg 2 times / day multiple, oral
Dose: 400 mg, 2 times / day
Route: oral
Route: multiple
Dose: 400 mg, 2 times / day
Sources:
unhealthy, 70 years
n = 1
Health Status: unhealthy
Age Group: 70 years
Sex: M
Population Size: 1
Sources:
PubMed

PubMed

TitleDatePubMed
Analgesic effectiveness of phenyramidol hydrochloride, a new aminopyridine derivative.
1959 Sep
Pharmacology of phenyramidol (IN511) with emphasis on analgesic and muscle-relaxant effects.
1960 Mar 30
Phenyramidol-associated liver toxicity.
2003 Sep
Patents

Patents

Substance Class Chemical
Created
by admin
on Fri Dec 15 18:39:24 GMT 2023
Edited
by admin
on Fri Dec 15 18:39:24 GMT 2023
Record UNII
H670S81Z1V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PHENYRAMIDOL SALICYLATE
Common Name English
FENYRAMIDOL SALICYLATE
Common Name English
Code System Code Type Description
PUBCHEM
56842255
Created by admin on Fri Dec 15 18:39:24 GMT 2023 , Edited by admin on Fri Dec 15 18:39:24 GMT 2023
PRIMARY
CAS
1235-07-0
Created by admin on Fri Dec 15 18:39:24 GMT 2023 , Edited by admin on Fri Dec 15 18:39:24 GMT 2023
PRIMARY
FDA UNII
H670S81Z1V
Created by admin on Fri Dec 15 18:39:24 GMT 2023 , Edited by admin on Fri Dec 15 18:39:24 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
ACTIVE MOIETY